AMP Capital Investors Ltd boosted its stake in shares of Cooper Companies Inc (NYSE:COO) by 1.5% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 20,264 shares of the medical device company’s stock after buying an additional 300 shares during the period. AMP Capital Investors Ltd’s holdings in Cooper Companies were worth $4,804,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the stock. Schwab Charles Investment Management Inc. increased its holdings in shares of Cooper Companies by 5.6% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 244,686 shares of the medical device company’s stock worth $58,583,000 after purchasing an additional 13,004 shares in the last quarter. Advisors Asset Management Inc. increased its holdings in shares of Cooper Companies by 0.6% in the 2nd quarter. Advisors Asset Management Inc. now owns 14,668 shares of the medical device company’s stock worth $3,512,000 after purchasing an additional 90 shares in the last quarter. State of Wisconsin Investment Board increased its holdings in shares of Cooper Companies by 30.5% in the 2nd quarter. State of Wisconsin Investment Board now owns 59,095 shares of the medical device company’s stock worth $14,149,000 after purchasing an additional 13,810 shares in the last quarter. Legal & General Group Plc increased its holdings in shares of Cooper Companies by 15.9% in the 2nd quarter. Legal & General Group Plc now owns 96,704 shares of the medical device company’s stock worth $23,149,000 after purchasing an additional 13,239 shares in the last quarter. Finally, Comerica Bank increased its holdings in shares of Cooper Companies by 70.1% in the 2nd quarter. Comerica Bank now owns 22,983 shares of the medical device company’s stock worth $5,760,000 after purchasing an additional 9,472 shares in the last quarter. 96.79% of the stock is owned by institutional investors.

Shares of Cooper Companies Inc (COO) opened at $229.30 on Friday. The company has a quick ratio of 1.26, a current ratio of 2.41 and a debt-to-equity ratio of 0.36. Cooper Companies Inc has a fifty-two week low of $172.83 and a fifty-two week high of $256.39. The company has a market capitalization of $11,005.75, a price-to-earnings ratio of 23.13, a P/E/G ratio of 1.82 and a beta of 0.54.

Cooper Companies (NYSE:COO) last issued its quarterly earnings data on Thursday, December 7th. The medical device company reported $2.65 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.64 by $0.01. Cooper Companies had a return on equity of 16.02% and a net margin of 17.43%. The company had revenue of $561.50 million during the quarter, compared to analyst estimates of $558.86 million. During the same quarter in the previous year, the company posted $2.28 earnings per share. Cooper Companies’s revenue was up 8.3% compared to the same quarter last year. analysts forecast that Cooper Companies Inc will post 11.51 EPS for the current fiscal year.

A number of analysts have commented on COO shares. Robert W. Baird reissued a “buy” rating and issued a $273.00 target price (up previously from $267.00) on shares of Cooper Companies in a report on Tuesday, September 12th. Zacks Investment Research raised Cooper Companies from a “hold” rating to a “buy” rating and set a $277.00 target price for the company in a report on Tuesday, August 29th. Stifel Nicolaus reissued a “buy” rating and issued a $265.00 target price (down previously from $275.00) on shares of Cooper Companies in a report on Friday, December 8th. Oppenheimer reissued a “hold” rating and issued a $250.00 target price on shares of Cooper Companies in a report on Tuesday, September 12th. Finally, Cleveland Research reissued a “buy” rating on shares of Cooper Companies in a report on Tuesday, August 22nd. Six analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $259.70.

ILLEGAL ACTIVITY NOTICE: “AMP Capital Investors Ltd Has $4.80 Million Position in Cooper Companies Inc (COO)” was first posted by Watch List News and is the sole property of of Watch List News. If you are reading this story on another site, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be read at https://www.watchlistnews.com/amp-capital-investors-ltd-has-4-80-million-position-in-cooper-companies-inc-coo/1767451.html.

Cooper Companies Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with Analyst Ratings Network's FREE daily email newsletter.